Back to User profile » Dr Maria Chiara Valentino

Papers published by Dr Maria Chiara Valentino:


Administrative Databases and Diagnostic Therapeutic and Assistance Paths -PDTA- in the Monitoring Treatment of Rheumatoid Arthritis: The Experience of ATS Pavia

Bruno GM, Valentino MC, Brunetti A, Di Matteo S, Begovic I, Croce E, Sakellariou G, Bugatti S, Perotti P, Vecchio S, Migliazza S, Langella R, Colombo GL

Pragmatic and Observational Research 2023, 14:29-38

Published Date: 19 April 2023

Economic Burden of Non-Alcoholic Steatohepatitis (NASH) Among Diabetic Population in Italy: Analysis and Perspectives

Torre E, Di Matteo S, Bruno GM, Martinotti C, Valentino MC, Testino G, Rebora A, Bottaro LC, Colombo GL

ClinicoEconomics and Outcomes Research 2022, 14:607-618

Published Date: 14 September 2022

Economic Impact of COVID-19 Lockdown on Italian NHS: Focus on Diabetes Mellitus

Torre E, Colombo GL, Di Matteo S, Martinotti C, Valentino MC, Rebora A, Cecoli F, Monti E, Galimberti M, Di Bartolo P, Gaggioli G, Bruno GM

ClinicoEconomics and Outcomes Research 2021, 13:503-518

Published Date: 14 June 2021

Economic Evaluation of Dulaglutide vs Traditional Therapies: Implications of the Outcomes of the Rewind Study

Torre E, Bruno GM, Di Matteo S, Martinotti C, Valentino MC, Bottaro LC, Colombo GL

ClinicoEconomics and Outcomes Research 2020, 12:177-189

Published Date: 8 April 2020

Cost-minimization analysis of degludec/liraglutide versus glargine/aspart: economic implications of the DUAL VII study outcomes

Torre E, Bruno GM, Di Matteo S, Martinotti C, Oselin M, Valentino MC, Parodi A, Bottaro LC, Colombo GL

ClinicoEconomics and Outcomes Research 2018, 10:413-421

Published Date: 26 July 2018

Economic burden of Clostridium difficile in five hospitals of the Florence health care system in Italy

Poli A, Di Matteo S, Bruno GM, Fornai E, Valentino MC, Colombo GL

Risk Management and Healthcare Policy 2015, 8:207-213

Published Date: 18 November 2015